Dihydroergotamine Mesylate Nasal
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Dihydroergotamine Mesylate Nasal, covering 2020-05-20 to 2023-09-12. Get the full timeline:
Most recent: FDA Approved: DIHYDROERGOTAMINE MESYLATE NASAL — Supplemental Application (Cipla USA Inc.)